Gotham Asset Management LLC Grows Stock Position in Veralto Corporation $VLTO

Key Points

• Gotham Asset Management LLC increased its stake in Veralto Corporation (VLTO) by 26.7%, owning 187,533 shares valued at approximately $18.28 million after acquiring an additional 39,540 shares.
• Several institutional investors have also expanded their stakes in Veralto, with Vanguard Group and T. Rowe Price significantly increasing their shareholdings, indicating strong interest in the company.
• Analysts have given Veralto a consensus rating of "Moderate Buy" with an average price target of $113.43, while the company reported better-than-expected earnings, with a net margin of 16.65% for the recent quarter.

Gotham Asset Management LLC increased its stake in shares of Veralto Corporation (NYSE:VLTO - Free Report) by 26.7% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 187,533 shares of the company's stock after purchasing an additional 39,540 shares during the quarter. Gotham Asset Management LLC owned approximately 0.08% of Veralto worth $18,275,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the stock. Hall Laurie J Trustee increased its position in Veralto by 6.0% during the 1st quarter. Hall Laurie J Trustee now owns 20,082 shares of the company's stock valued at $1,957,000 after buying an additional 1,133 shares in the last quarter. Alliancebernstein L.P. increased its position in Veralto by 28.0% during the 1st quarter. Alliancebernstein L.P. now owns 6,235,563 shares of the company's stock valued at $607,656,000 after buying an additional 1,363,502 shares in the last quarter. AQR Capital Management LLC increased its position in Veralto by 133.2% during the 1st quarter. AQR Capital Management LLC now owns 455,220 shares of the company's stock valued at $43,842,000 after buying an additional 260,002 shares in the last quarter. Adage Capital Partners GP L.L.C. increased its position in Veralto by 545.9% during the 1st quarter. Adage Capital Partners GP L.L.C. now owns 200,667 shares of the company's stock valued at $19,555,000 after buying an additional 169,600 shares in the last quarter. Finally, EP Wealth Advisors LLC increased its position in Veralto by 13.2% during the 1st quarter. EP Wealth Advisors LLC now owns 2,583 shares of the company's stock valued at $252,000 after buying an additional 301 shares in the last quarter. 91.28% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the company. Stifel Nicolaus set a $120.00 target price on Veralto and gave the company a "buy" rating in a research report on Wednesday, July 30th. Wolfe Research raised Veralto from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, July 30th. Royal Bank Of Canada upped their target price on Veralto from $104.00 to $108.00 and gave the company a "sector perform" rating in a research report on Wednesday, July 30th. Robert W. Baird upped their target price on Veralto from $106.00 to $112.00 and gave the company a "neutral" rating in a research report on Wednesday, July 30th. Finally, Raymond James Financial began coverage on Veralto in a report on Tuesday, August 26th. They issued a "market perform" rating on the stock. Five analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $113.43.

Insider Buying and Selling at Veralto

In other news, CEO Jennifer Honeycutt sold 10,646 shares of the firm's stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $106.26, for a total value of $1,131,243.96. Following the transaction, the chief executive officer owned 106,219 shares in the company, valued at $11,286,830.94. This trade represents a 9.11% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.36% of the stock is currently owned by company insiders.

Veralto Stock Performance

Veralto stock traded up $2.71 during midday trading on Thursday, hitting $108.72. 343,339 shares of the company were exchanged, compared to its average volume of 1,328,957. The firm has a market capitalization of $26.98 billion, a PE ratio of 30.37, a price-to-earnings-growth ratio of 3.49 and a beta of 0.91. Veralto Corporation has a fifty-two week low of $83.86 and a fifty-two week high of $115.00. The business has a fifty day simple moving average of $105.30 and a two-hundred day simple moving average of $99.82. The company has a debt-to-equity ratio of 1.00, a quick ratio of 2.06 and a current ratio of 2.32.

Veralto (NYSE:VLTO - Get Free Report) last posted its earnings results on Monday, July 28th. The company reported $0.93 EPS for the quarter, topping the consensus estimate of $0.89 by $0.04. The firm had revenue of $1.37 billion for the quarter, compared to analyst estimates of $1.34 billion. Veralto had a return on equity of 41.45% and a net margin of 16.65%.Veralto's revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period last year, the company earned $0.85 earnings per share. Veralto has set its FY 2025 guidance at 3.720-3.800 EPS. Q3 2025 guidance at 0.910-0.950 EPS. On average, sell-side analysts forecast that Veralto Corporation will post 3.66 earnings per share for the current year.

Veralto Company Profile

Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands.